161 related articles for article (PubMed ID: 26666701)
1. Thermodynamic Insights and Conceptual Design of Skin-Sensitive Chitosan Coated Ceramide/PLGA Nanodrug for Regeneration of Stratum Corneum on Atopic Dermatitis.
Jung SM; Yoon GH; Lee HC; Jung MH; Yu SI; Yeon SJ; Min SK; Kwon YS; Hwang JH; Shin HS
Sci Rep; 2015 Dec; 5():18089. PubMed ID: 26666701
[TBL] [Abstract][Full Text] [Related]
2. PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.
Zou P; Stern ST; Sun D
Pharm Res; 2014 Mar; 31(3):684-93. PubMed ID: 24065591
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
[TBL] [Abstract][Full Text] [Related]
4. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
9. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
10. Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.
Shi Y; Xue J; Jia L; Du Q; Niu J; Zhang D
Colloids Surf B Biointerfaces; 2018 Jan; 161():67-72. PubMed ID: 29040836
[TBL] [Abstract][Full Text] [Related]
11. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
Lee BS; Lee CC; Wang YP; Chen HJ; Lai CH; Hsieh WL; Chen YW
Int J Nanomedicine; 2016; 11():285-97. PubMed ID: 26848264
[TBL] [Abstract][Full Text] [Related]
12. Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies.
Sahu P; Kashaw SK; Jain S; Sau S; Iyer AK
J Control Release; 2017 May; 253():122-136. PubMed ID: 28322977
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
Chronopoulou L; Massimi M; Giardi MF; Cametti C; Devirgiliis LC; Dentini M; Palocci C
Colloids Surf B Biointerfaces; 2013 Mar; 103():310-7. PubMed ID: 23261553
[TBL] [Abstract][Full Text] [Related]
14. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
16. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery.
Amoozgar Z; Park J; Lin Q; Yeo Y
Mol Pharm; 2012 May; 9(5):1262-70. PubMed ID: 22489704
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-PLGA polymer blends as coatings for hydroxyapatite nanoparticles and their effect on antimicrobial properties, osteoconductivity and regeneration of osseous tissues.
Ignjatović N; Wu V; Ajduković Z; Mihajilov-Krstev T; Uskoković V; Uskoković D
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():357-364. PubMed ID: 26706541
[TBL] [Abstract][Full Text] [Related]
19. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
20. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
